CDH8

Chr 16

cadherin 8

Also known as: Nbla04261

This protein is a type II cadherin that mediates calcium-dependent cell-cell adhesion in the brain and is involved in synaptic adhesion, axon outgrowth and guidance. Mutations cause autosomal dominant neurodevelopmental disorders including developmental and epileptic encephalopathy and autism spectrum disorder. The gene is highly constrained against loss-of-function variants (pLI 0.99, LOEUF 0.30), indicating that even single functional copies may be insufficient for normal brain development.

ResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.29
Clinical SummaryCDH8
Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 0.99). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
17 unique Pathogenic / Likely Pathogenic· 87 VUS of 125 total submissions
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint
0.29LOEUF
pLI 0.988
Z-score 4.49
OE 0.13 (0.060.29)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint
2.42Z-score
OE missense 0.68 (0.620.75)
315 obs / 461.2 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios
LoF OE0.13 (0.060.29)
00.351.4
Missense OE0.68 (0.620.75)
00.61.4
Synonymous OE1.06
01.21.6
LoF obs/exp: 4 / 31.0Missense obs/exp: 315 / 461.2Syn Z: -0.59
DN
0.6065th %ile
GOF
0.6541th %ile
LOF
0.58top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). The Badonyi & Marsh model scores gain-of-function highest among its predictions, but genomic evidence (constraint, ClinVar variant spectrum, and literature) most strongly supports loss-of-function (haploinsufficiency). Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOFLOEUF 0.29
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

125 submitted variants in ClinVar

Classification Summary

Pathogenic15
Likely Pathogenic2
VUS87
Likely Benign10
Benign2
15
Pathogenic
2
Likely Pathogenic
87
VUS
10
Likely Benign
2
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
15
0
15
Likely Pathogenic
0
0
2
0
2
VUS
2
74
11
0
87
Likely Benign
0
2
2
6
10
Benign
0
0
0
2
2
Total276308116

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CDH8 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →